<!DOCTYPE html>
<html lang="en">
<head>
  <title>
    eCFR :: 21 CFR 314.81 -- Other postmarketing reports.
  </title>

  <link rel="canonical" href="https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81" />

  <link rel="apple-touch-icon" sizes="180x180" href="/assets/favicon/apple-touch-icon-18ac1159c2217e79fb45c21adc630384b65af33c4e6de8eca0ff8527a4fe080e.png">
<link rel="icon" type="image/png" sizes="32x32" href="/assets/favicon/favicon-32x32-601e211398bdd3b5d26f99ae1ddae16e940b6a6223cb83f429419e6709f596f2.png">
<link rel="icon" type="image/png" sizes="16x16" href="/assets/favicon/favicon-16x16-8e7cf46953c8eadd70c27e99d2977556a7ad517c1d809782451b24be80323d14.png">
<link rel="manifest" href="/assets/favicon/site-17bc871d6b501401cd30d1f57e54a581f21f9c964717dd77d28e6f026da4b560.webmanifest">
<link rel="mask-icon" href="/assets/favicon/safari-pinned-tab-42724ccbb4192754e3500f02bee26d07b1c8432d7179433dd34d8d59c4e0882b.svg" color="#fab827">
<link rel="shortcut icon" href="/assets/favicon/favicon-014ef9fe5cc7969da15185d0790dba54c9c41bbcedda5477f9a7214d98263525.ico">
<meta name="msapplication-TileColor" content="#ffc40d">
<meta name="msapplication-config" content="/assets/favicon/browserconfig-d9fe2961ea6e1d05b91dec740f2c7b3b916c646691e7c909c258dea3ad28cd94.xml">
<meta name="theme-color" content="#ffffff">


    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script src="/assets/google_analytics-a2da3bb5c78c39ec6f425a2de69612f49200191a66f6aaac3b373bc53618cf0e.js" async="async" nonce="0NNuAsdvvtNdRcTCtg1UHQ=="></script>

    <!-- We participate in the US government's analytics program. See the data at analytics.usa.gov. -->
    <script async type="text/javascript" nonce="0NNuAsdvvtNdRcTCtg1UHQ==" src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=NARA&subagency=fedreg" id="_fed_an_ua_tag"></script>

  <link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link
href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,400;0,500;0,600;0,700;1,400;1,500;1,700&family=Bitter:ital,wght@0,400;0,500;0,700;1,400;1,500;1,700&display=swap"
rel="preload"
as="style">
<link
href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,400;0,500;0,600;0,700;1,400;1,500;1,700&family=Bitter:ital,wght@0,400;0,500;0,700;1,400;1,500;1,700&display=swap"
rel="stylesheet">


  <link rel="stylesheet" media="all" href="/assets/vendor-ed1f17021e0f5e5ba9861e9a88550a0d17aa9657d0832f953e6156a822fe3a1d.css" data-turbo-track="true" />
  <link rel="stylesheet" media="all" href="/assets/application-cab3fe704abacf30de204627077d84af75f499a7a95a6ebf38ab9f441d80db4b.css" data-turbo-track="true" />
  <link rel="stylesheet" media="print" href="/assets/print-e85ef07360cd8210c510308470ec9745d5d7b31065d9007a9d9b6935c561c232.css" data-turbo-track="true" />

  <script src="/assets/application_pipeline-f0d1acd760914e71ab29e1f38e053541718074f2c78f698d20cf47fa0dacd70a.js" data-turbo-eval="false" async="async" defer="defer" nonce="0NNuAsdvvtNdRcTCtg1UHQ=="></script>

  <script type="importmap" data-turbo-track="reload" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">{
  "imports": {
    "application": "/assets/application-335c9d0168c1b2a3960dd56fdf4f6c209d0eec1942adb72b6441483bed14e77f.js",
    "@hotwired/turbo-rails": "/assets/turbo.min-f971c8640d593387ea5afa6f0b3f51d9868c8ab3b4ddf1c811da0ed00d67af2d.js",
    "@hotwired/stimulus": "https://ga.jspm.io/npm:@hotwired/stimulus@3.2.2/dist/stimulus.js",
    "@hotwired/stimulus-loading": "/assets/stimulus-loading-6024ee603e0509bba59098881b54a52936debca30ff797835b5ec6a4ef77ba37.js",
    "@lodash/debounce": "https://ga.jspm.io/npm:lodash.debounce@4.0.8/index.js",
    "stimulus-autocomplete": "/assets/stimulus-autocomplete-0e2d350d1a0100abce1840193618fa0e606c0425d5631eb27dee0fb068cc32df.js",
    "stimulus-use": "https://ga.jspm.io/npm:stimulus-use@0.52.0/dist/index.js",
    "controllers/agencies_controller": "/assets/controllers/agencies_controller-b39755bd0bdc29806a7e88bb2015c8cb873f41228c3332df2a9a0b91e94af87c.js",
    "controllers/application": "/assets/controllers/application-e361dd5f2e228c2fb25a1549ad19f7ab2ee254e8123572f3fb9694ad08711254.js",
    "controllers/changes_controller": "/assets/controllers/changes_controller-7d46a5241e38838956e42fa95fe3b8a38901c1c5c739c623498328449cb8f6d1.js",
    "controllers/compare_controller": "/assets/controllers/compare_controller-d4c7c2f7183e9a0487fb4156d3be50ca77ced0e1881289fbe3b0920b4a88ec95.js",
    "controllers/element_controller": "/assets/controllers/element_controller-124c5e519399db700016351f28875d1aebd96b8966ef7655beb3e8ec42529c3e.js",
    "controllers/form_controller": "/assets/controllers/form_controller-521a8ae5e19bf25bcf358a35c386589c4ae49399968da815af3e5fedb4e66cad.js",
    "controllers": "/assets/controllers/index-075d84f1ecd1595c9ab3e04d66cb668dc9f6fb81d4809c437cbb0a5c0ec6fce2.js",
    "controllers/modal_controller": "/assets/controllers/modal_controller-b9cff36cd77bfb60e03304caa4eecacff19fc3713510141975d9e6f2748ac706.js",
    "controllers/placeholder_controller": "/assets/controllers/placeholder_controller-db5bbdf7df068e036eb77a730c74a68b59d680045962165deb575098d64ea172.js",
    "controllers/recent_changes_controller": "/assets/controllers/recent_changes_controller-b55783709d43d67c169ce404aad187bb8a49f140d816a203405cc382ae31d605.js",
    "controllers/suggestions_controller": "/assets/controllers/suggestions_controller-c86bd514065aba875525a390293adf8e27176ccdd869a92a035c06b027e67771.js",
    "controllers/timeline_controller": "/assets/controllers/timeline_controller-d797067edc737523ee3485893dd7f9f0e658d0e421b93ec3657bd7dcf6d9d1d2.js"
  }
}</script>
<link rel="modulepreload" href="/assets/application-335c9d0168c1b2a3960dd56fdf4f6c209d0eec1942adb72b6441483bed14e77f.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/turbo.min-f971c8640d593387ea5afa6f0b3f51d9868c8ab3b4ddf1c811da0ed00d67af2d.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="https://ga.jspm.io/npm:@hotwired/stimulus@3.2.2/dist/stimulus.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/stimulus-loading-6024ee603e0509bba59098881b54a52936debca30ff797835b5ec6a4ef77ba37.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="https://ga.jspm.io/npm:lodash.debounce@4.0.8/index.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/stimulus-autocomplete-0e2d350d1a0100abce1840193618fa0e606c0425d5631eb27dee0fb068cc32df.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="https://ga.jspm.io/npm:stimulus-use@0.52.0/dist/index.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/agencies_controller-b39755bd0bdc29806a7e88bb2015c8cb873f41228c3332df2a9a0b91e94af87c.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/application-e361dd5f2e228c2fb25a1549ad19f7ab2ee254e8123572f3fb9694ad08711254.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/changes_controller-7d46a5241e38838956e42fa95fe3b8a38901c1c5c739c623498328449cb8f6d1.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/compare_controller-d4c7c2f7183e9a0487fb4156d3be50ca77ced0e1881289fbe3b0920b4a88ec95.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/element_controller-124c5e519399db700016351f28875d1aebd96b8966ef7655beb3e8ec42529c3e.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/form_controller-521a8ae5e19bf25bcf358a35c386589c4ae49399968da815af3e5fedb4e66cad.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/index-075d84f1ecd1595c9ab3e04d66cb668dc9f6fb81d4809c437cbb0a5c0ec6fce2.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/modal_controller-b9cff36cd77bfb60e03304caa4eecacff19fc3713510141975d9e6f2748ac706.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/placeholder_controller-db5bbdf7df068e036eb77a730c74a68b59d680045962165deb575098d64ea172.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/recent_changes_controller-b55783709d43d67c169ce404aad187bb8a49f140d816a203405cc382ae31d605.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/suggestions_controller-c86bd514065aba875525a390293adf8e27176ccdd869a92a035c06b027e67771.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<link rel="modulepreload" href="/assets/controllers/timeline_controller-d797067edc737523ee3485893dd7f9f0e658d0e421b93ec3657bd7dcf6d9d1d2.js" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">
<script type="module" nonce="0NNuAsdvvtNdRcTCtg1UHQ==">import "application"</script>

  

  <meta name="viewport" content="width=970">
  <meta name="format-detection" content="telephone=no">
    <meta name="dcterms.title"
    content="21 CFR 314.81 -- Other postmarketing reports." />
	<meta name="dcterms.bibliographicCitation"
    content="21 CFR 314.81" />

  <meta property="og:title"
    content="21 CFR 314.81 -- Other postmarketing reports." />
  <meta property="og:url"
    content="/current/title-21/part-314/section-314.81" />

  <meta property="ecfr:citationDate"
    content="" />


</head>
  <body data-environment="production" data-honeybadger-js-api-key="f722cff2" data-revision="727e54f755c0a30ba8c7a3c0ae6738aba3fa628b" data-google-ga4-tag="G-K7SMYBYX81" data-service="ecfr-web" data-domain=".ecfr.gov">

    <!-- Zendesk Form -->
      <div class="btn" id="feedbackbutton" type="button"><span class="icon-ecfr-chat"></span>Site Feedback</div>
      <div id="legacy_browser_modal" class="modal fade" role="dialog" aria-labelledby="genericModal" aria-hidden="true" tabindex="-1">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">You are using an unsupported browser
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
        <span aria-hidden="true">&times;</span>
        </h5>
      </div>
      <div class="modal-body">
        <p>
          You are using an unsupported browser. This web site is designed for the current versions of
          Microsoft Edge, Google Chrome, Mozilla Firefox, or Safari.
        </p>
      </div>
    </div>
  </div>
</div>

      <div id="interstitial-feedback-modal" class="modal fade in" aria-hidden="true" tabindex="-1" role="dialog" aria-labelledby="Feedback: Contact Us">
  <div class="modal-dialog" role="document">
    <div class="modal-content">
      <div class="modal-header">
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">×</span>
        </button>
        <h3 class="text-center">Site Feedback</h3>
      </div>
      <div class="modal-body">
        <p>
          The Office of the Federal Register publishes documents on behalf of Federal agencies but does not have any authority over their programs. We recommend you directly contact the agency associated with the content in question.
        </p>
        <hr>
        <div class="row">
          <div id="website-feedback" class="col-xs-6 col-md-6 feedback-section">
            <p>
              If you have comments or suggestions on how to improve the www.ecfr.gov website or have questions about using www.ecfr.gov, please choose the 'Website Feedback' button below.
            </p>
            <div class="text-center">
              <a class="btn btn-primary btn-medium text-center" href="">
                <div><span class="icon-ecfr icon-ecfr-help "></span></div>
                Website Feedback
</a>            </div>
          </div>
          <div id="content-feedback" class="col-xs-6 col-md-6 feedback-section">
            <p>
              If you would like to comment on the current content, please use the 'Content Feedback' button below for instructions on contacting the issuing agency
            </p>
            <div class="text-center">
              <a class="btn btn-primary btn-medium text-center" href="">
                <div><span class="icon-ecfr icon-ecfr-legal "></span></div>
                Content Feedback
</a>            </div>
          </div>
        </div>
        <div class="text-center small-text">If you have questions for the Agency that issued the current document please contact the agency directly.</div>
      </div>
    </div>
  </div>
</div>

      <div id="zendesk-feedback-modal">
  <div class="modal-content zendesk-modal-content">
    <div class="modal-header">
      <button type="button" class="close" data-dismiss="modal" aria-label="Close">
        <span aria-hidden="true">×</span>
      </button>
      <h3>Website Feedback</h3>
    </div>

    <div class="modal-body">
      <form novalidate="novalidate" class="simple_form zendesk_ticket" enctype="multipart/form-data" action="/zendesk_tickets" accept-charset="UTF-8" method="post">
        <div class="form-group string required zendesk_ticket_name"><label class="control-label string required" for="zendesk_ticket_name"><abbr title="required">*</abbr> Your Name</label><input class="form-control string required" required="required" aria-required="true" type="text" name="zendesk_ticket[name]" id="zendesk_ticket_name" /></div>
        <div class="form-group email required zendesk_ticket_email"><label class="control-label email required" for="zendesk_ticket_email"><abbr title="required">*</abbr> Email</label><input class="form-control string email required" required="required" aria-required="true" type="email" name="zendesk_ticket[email]" id="zendesk_ticket_email" /></div>
        <div class="form-group file optional zendesk_ticket_attachment"><label class="control-label file optional" for="zendesk_ticket_attachment">Attachment</label><input class="file optional" type="file" name="zendesk_ticket[attachment]" id="zendesk_ticket_attachment" /></div>
        <div class="form-group text required zendesk_ticket_comment"><label class="control-label text required" for="zendesk_ticket_comment"><abbr title="required">*</abbr> How can we help you?</label><textarea class="form-control text required" name="zendesk_ticket[comment]" id="zendesk_ticket_comment">
</textarea></div>
        <div class="form-group boolean required zendesk_ticket_technical_help"><div class="checkbox"><input value="0" autocomplete="off" type="hidden" name="zendesk_ticket[technical_help]" /><label class="boolean required" for="zendesk_ticket_technical_help"><input class="boolean required" required="required" aria-required="true" type="checkbox" value="1" name="zendesk_ticket[technical_help]" id="zendesk_ticket_technical_help" /><abbr title="required">*</abbr> I am requesting technical help or providing website feedback</label></div></div>
          <div class="modal-text">
            This contact form is only for website help or website suggestions. If you have questions or comments regarding a published document please
            contact the publishing agency. Comments or questions about document content can not be answered by OFR staff. Please do not provide confidential
            information or personal data.
          </div>
        <div class="form-group text-left">
          <input type="submit" name="commit" value="Create Ticket" class="btn btn-primary btn-medium" data-disable-with="Create Ticket" />
        </div>
</form>    </div>
  </div>
</div>


    

    <div class="container">
      <div class='row'>
        <div class="col-xs-12 col-md-12 layout-header">
          <div class="main-navigation" id="main-navigation">
  <ul class="container">
    <li id='nav-home' class="nav-home" tabindex>
      <a class="home" aria-label="Home" href="/">
        <span class="icon-ecfr icon-ecfr-home "></span>
</a>    </li>

    <li id='nav-browse' class="dropdown nav-browse" tabindex=0>
      <a class="top-nav">
        <span class="icon-ecfr icon-ecfr-eye "></span>
        Browse
        <span class="icon-ecfr icon-ecfr-menu-arrow "></span>
      </a>

      <ul class="subnav dropdown-list">
        <li>
          <a href="/titles"><span class="icon-ecfr icon-ecfr-book "></span> Titles</a>
        </li>
        <li>
          <a href="/agencies"><span class="icon-ecfr icon-ecfr-mindmap "></span> Agencies</a>
        </li>
        <li>
          <a href="/incorporation-by-reference"><span class="icon-ecfr icon-ecfr-directions-alt "></span> Incorporation by Reference</a>
        </li>
        <li>
          <a href="/issues"><span class="icon-ecfr icon-ecfr-hourglass "></span> Recent Updates</a>
        </li>
      </ul>
    </li>

    <li id='nav-search' class="nav-search" tabindex>
      <a class="search" aria-label="eCFR Search" href="/search">
        <span class="icon-ecfr icon-ecfr-search "></span> Search
</a>    </li>

    <li id='nav-recent-changes' class="nav-recent-changes" tabindex>
      <a aria-label="eCFR Recent Changes" href="/recent-changes">
        <span class="icon-ecfr icon-ecfr-hourglass "></span> Recent Changes
</a>    </li>

    <li id='nav-ecfr-corrections' class="nav-recent-changes" tabindex>
      <a aria-label="eCFR Corrections" href="/corrections/2025">
        <span class="icon-ecfr icon-ecfr-merge "></span> Corrections
</a>    </li>

    <li id='nav-reader-aids' class="dropdown nav-reader-aids" tabindex=0>
      <a class="top-nav">
        <span class="icon-ecfr icon-ecfr-directions "></span>
        Reader Aids
        <span class="icon-ecfr icon-ecfr-menu-arrow "></span>
      </a>

      <ul class="subnav dropdown-list hierarchical" tabindex=0>
        <li>
          <a tabindex="0" href="/reader-aids">Reader Aids Home</a>
        </li>
          <li>
            <a tabindex="0" href="/reader-aids/using-ecfr">Using the eCFR Point-in-Time System</a>
          </li>
          <li>
            <a tabindex="0" href="/reader-aids/understanding-the-ecfr">Understanding the eCFR</a>
          </li>
          <li>
            <a tabindex="0" href="/reader-aids/government-policy-and-ofr-procedures">Government Policy and OFR Procedures</a>
          </li>
          <li>
            <a tabindex="0" href="/reader-aids/ecfr-developer-resources">Developer Resources</a>
          </li>
      </ul>
    </li>

    <li id='nav-my-ecfr' class="dropdown nav-my-ecfr" tabindex=0>
      <a class="top-nav">
        <span class="icon-ecfr icon-ecfr-male-female-user "></span>
        My eCFR
        <span class="icon-ecfr icon-ecfr-menu-arrow "></span>
      </a>

      <ul class="subnav dropdown-list signed-in hidden" tabindex=0>
        <li>
          <a href="/my/subscriptions">My Subscriptions</a>
        </li>
        <li>
          <a data-turbo="false" href="/sign_out">Sign Out</a>
        </li>
      </ul>

      <ul class="subnav dropdown-list signed-out" tabindex=0>
        <li>
          <a data-turbo="false" href="https://www.ecfr.gov/auth/sign_in?jwt=eyJhbGciOiJIUzI1NiJ9.eyJub3RpZmljYXRpb25zIjp7ImluZm8iOiJZb3Ugd2lsbCBiZSByZWRpcmVjdGVkIGJhY2sgdG8gdGhlIGVDRlIgYWZ0ZXIgeW91IGhhdmUgc2lnbmVkIGluIG9yIGNyZWF0ZWQgYW4gYWNjb3VudC4ifX0.-sYkHWfC02yb0CpuUqmPkxxnF0yzlNHaS5520hYIUy8&amp;redirect_to=https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81">Sign In / Sign Up</a>
        </li>
      </ul>
    </li>

    <li id='nav-inline-search' class="nav-inline-search" data-controller="placeholder">
      <form class="simple_form nav-search-form" novalidate="novalidate" action="/search" accept-charset="UTF-8" method="get">
        <input value="current" class="hidden" autocomplete="off" type="hidden" name="search[date]" id="search_date" />

          <input value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;D&quot;,&quot;part&quot;:&quot;314&quot;,&quot;subpart&quot;:&quot;B&quot;,&quot;section&quot;:&quot;314.81&quot;}" autocomplete="off" type="hidden" name="search[prior_hierarchy]" id="search_prior_hierarchy" />

        <input autocomplete="off" class="string required nav-search-query" data-action="click-&gt;placeholder#suggestions" placeholder="Search the eCFR" type="text" name="search[query]" id="search_query" />

        <button name="button" type="submit" class="nav-search-btn" title="Search" data-action="click-&gt;placeholder#suggestions">
          <span class="icon-ecfr icon-ecfr-search "></span>
</button>
        <div class='current-hierarchy-dropdown hidden'>
        </div>
</form>    </li>
  </ul>

  <div class='user-utils'>
    <div class='signed-out'>
      <a class="utils-signed-out" tabindex="-1" data-turbo="false" href="https://www.ecfr.gov/auth/sign_in?jwt=eyJhbGciOiJIUzI1NiJ9.eyJub3RpZmljYXRpb25zIjp7ImluZm8iOiJZb3Ugd2lsbCBiZSByZWRpcmVjdGVkIGJhY2sgdG8gdGhlIGVDRlIgYWZ0ZXIgeW91IGhhdmUgc2lnbmVkIGluIG9yIGNyZWF0ZWQgYW4gYWNjb3VudC4ifX0.-sYkHWfC02yb0CpuUqmPkxxnF0yzlNHaS5520hYIUy8&amp;redirect_to=https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81">Sign In / Sign Up</a>
    </div>

    <div class='signed-in hidden'>
      <p>
        Hi, <span class='user-email'></span>
          <a data-turbo="false" tabindex="-1" href="/sign_out">Sign Out</a>
      </p>
    </div>
  </div>
</div>


<div class="container">
  <div class="row">
    <div class="col-xs-12">
      <div class="logo">
        <div class="hgroup standard">
          <hgroup>
            <h1><a href="/" title="eCFR Home" tabindex=-1>eCFR</a></h1>
            <h2>The Electronic Code of Federal Regulations</h2>
          </hgroup>
        </div>
      </div>
    </div>
  </div>
</div>


        </div>
      </div>
    </div>

    <div class="container">
      <div class='external-url-modal'></div>
      <div class="modal fr-citation-modal" id="frCitationModal" tabindex="-1" role="dialog" aria-labelledby="Federal Register Citation Modal">
        <div class="modal-dialog" role="document">
          <div class="modal-content">
            <span class="icon-ecfr icon-ecfr-badge-x "></span>
            <div class="box box-enhanced "><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content :: FR Reference</h6><div class="row seal-meta"><div class="seal-desc col-md-12 col-xs-12"><p>Enhanced content is provided to the user to provide additional context.</p></div></div></div></div><div class="content-block ">
              <div class="modal-body"></div>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content :: FR Reference</h6></div></div>          </div>
        </div>
      </div>

      <div class='row'>
        <div class="col-xs-12 col-md-12 title-bar-col">
          <div id="page-top" class="main-title-bar "><div class="bar left"></div><h1 class="">  <span class="icon-ecfr icon-ecfr-books "></span>
  Title 21
</h1><div class="bar right"></div></div>
        </div>
      </div>


          <div class="row " >
  <div class="col-xs-12 col-md-12 content-notification basic print-only print-only-legal-notice"
    id="content-notification-f4223aa6"
  >
    <div class="">

      

      <div class="message">
        <p>This content is from the eCFR and is authoritative but unofficial.<p>
      </div>

    </div>
  </div>
</div>

  <div class="row " >
  <div class="col-xs-12 col-md-12 content-notification info"
    id="content-notification-5d2dd8bb"
  >
    <div class="">

      <span class="icon-ecfr icon-ecfr-calendar-alt "></span>

      <div class="message">
        Displaying title 21, up to date as of 4/21/2025. Title 21 was last amended 4/12/2025.<span class="reader-aid"><span data-toggle="tooltip" data-title="Click to learn more about dates in eCFR." class="svg-tooltip clickable" data-url="/reader-aids/understanding-the-ecfr/what-is-the-ecfr#special-rules-and-proceedures-for-future-amendments" data-container="span.reader-aid"><svg class="ecfr-svg-icon ecfr-svg-icon-info-circle "><use xlink:href="/assets/ecfr-icons-c08c495b1eda093da23b5b159c24927a91aa7c13df40f52ca7d30476904de0ea.svg#ecfr-svg-icon-info-circle"></use></svg></span></span>
      </div>

        <div class="message-link">
          <a class="msg-link message-go-to-version" href="#">view historical versions</a>
        </div>
    </div>
  </div>
</div>

  <div class="row hidden" >
  <div class="col-xs-12 col-md-12 content-notification danger"
    id="drafting-site-notification"
  >
    <div class="">
        <div class="dismiss-link">
          <span class="icon-ecfr icon-ecfr-badge-x "></span>
        </div>

      <span class="icon-ecfr icon-ecfr-alert-alt "></span>

      <div class="message">
        A <a data-drafting="true" href="https://drafting.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81">drafting site is available</a> for use when drafting amendatory language
      </div>

        <div class="message-link">
          <a data-drafting="true" class="msg-link" href="https://drafting.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81">switch to drafting site</a>
        </div>
    </div>
  </div>
</div>






      <div class='row'>
        <div class="col-xs-12 col-md-12 content-col">
          <div>
  <div id="suggestions" data-controller="suggestions autocomplete"
    data-autocomplete-url-value="/suggestions"
    data-autocomplete-delay-value="300">

    <div class="modal hidden" data-controller="modal"
      data-action="keyup@document->modal#escClose"
      data-suggestions-target="modal">

      <button class="backdrop" type="button" tabindex="-1"
        data-action="modal#close"></button>

      <div class="content">

        <div class="panel panel-default panel-info" data-suggestions-target="help">
          <div class="panel-heading">
            <p>
              <strong>Navigate by entering citations or phrases</strong>
              (eg:
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">1 CFR 1.1</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">49 CFR 172.101</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">Organization and Purpose</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">1/1.1</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">Regulation Y</span>
                <span data-action="click->suggestions#fillExample"
                  class="example badge badge-info">FAR</span>).
            </p>
            <p>
              Choosing an item from
              <span class="suggestion-header-example">citations and headings</span>
              will bring you directly to the content. Choosing an item from
              <span class="suggestion-header-example">full text search results</span>
              will bring you to those results. Pressing enter in the search box
              will also bring you to search results.
            </p>
            <p>
              Background and more details are available in the
              <em>
                <a href="/reader-aids/using-ecfr/navigating-to-content-of-interest#search-navigation">Search &amp; Navigation</a>
              </em>
              guide.
            </p>
          </div>
        </div>

        <div class="cfr-ref-wrapper go-to-cfr-reference">
          <form class="simple_form go-to-cfr-reference" data-suggestions-target="form" data-turbo="false" novalidate="novalidate" action="/cfr-reference" accept-charset="UTF-8" method="get">
            <input value="current" data-param="date" autocomplete="off" type="hidden" name="search[date]" id="search_date" />
            <input value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;D&quot;,&quot;part&quot;:&quot;314&quot;,&quot;subpart&quot;:&quot;B&quot;,&quot;section&quot;:&quot;314.81&quot;}" data-param="hierarchy" autocomplete="off" type="hidden" name="search[hierarchy]" id="search_hierarchy" />
            <input value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;D&quot;,&quot;part&quot;:&quot;314&quot;,&quot;subpart&quot;:&quot;B&quot;,&quot;section&quot;:&quot;314.81&quot;}" data-param="prior_hierarchy" autocomplete="off" type="hidden" name="search[prior_hierarchy]" id="search_prior_hierarchy" />

            <div class="input-group input-group-lg">
              <input type="text" class="form-control"
                placeholder="Enter a search term or CFR reference (eg. fishing or 1 CFR 1.1)"
                aria-describedby="reference-search-icon"
                data-autocomplete-target="input"
                data-suggestions-target="input"
                name="search[query]"
                id="suggestion_query">

              <span class="input-group-btn"
                id="reference-search-icon"
                aria-label="search">
                <button class="btn btn-optional" type="button"
                  data-suggestions-target="searchIcon"
                  data-action="click->suggestions#goDefault">
                    <span class="icon-ecfr icon-ecfr-search "></span>
                </button>
              </span>
            </div>

            <div data-autocomplete-target="results"
              data-suggestions-target="results"></div>
</form>        </div>

      </div>
    </div>

    <form class="simple_form go-to-cfr-reference hidden" data-suggestions-target="nonModalForm" novalidate="novalidate" action="/cfr-reference" accept-charset="UTF-8" method="get">
      <input label="false" value="current" autocomplete="off" type="hidden" name="cfr[date]" id="cfr_date" />
      <input value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;D&quot;,&quot;part&quot;:&quot;314&quot;,&quot;subpart&quot;:&quot;B&quot;,&quot;section&quot;:&quot;314.81&quot;}" autocomplete="off" type="hidden" name="cfr[prior_hierarchy]" id="cfr_prior_hierarchy" />
      <input data-autocomplete-target="hidden" autocomplete="off" type="hidden" name="cfr[suggestion_id]" id="cfr_suggestion_id" />

      <div class="input-group input-group-lg">
        <input type="text" class="form-control string optional"
          data-action="focus->suggestions#modal"
          placeholder="Enter a search term or CFR reference (eg. fishing or 1 CFR 1.1)"
          type="text"
          data-suggestions-target="nonModalInput"
          name="cfr[reference]"
          id="suggestion">
        <span class="input-group-btn"
          data-action="click->suggestions#go">

          <button class="btn btn-optional" type="button"
            data-suggestions-target="nonModalSearchIcon"
            data-action="click->suggestions#go">
              <span class="icon-ecfr icon-ecfr-search "></span>
          </button>
        </span>
      </div>
</form>  </div>
</div>

          



<div class='row'>
  <div class="col-xs-12 col-md-12 no-padding">
    <div class='cfr-ref-wrapper'>
  <div data-controller="placeholder">
    <form class="simple_form go-to-cfr-reference" novalidate="novalidate" action="/cfr-reference" accept-charset="UTF-8" method="get">

      <div class="input-group input-group-lg">
        <input type="text" class="form-control string optional"
          data-action="focus->placeholder#suggestions"
          placeholder="Enter a search term or CFR reference (eg. fishing or 1 CFR 1.1)"
          type="text"
          data-suggestions-target="nonModalInput"
          name="cfr[reference]"
          id="suggestion">
        <span class="input-group-btn"
          data-action="click->placeholder#suggestions">

          <button class="btn btn-optional" type="button"
            data-suggestions-target="nonModalSearchIcon"
            data-action="click->placeholder#suggestions">
              <span class="icon-ecfr icon-ecfr-search "></span>
          </button>
        </span>
      </div>
</form>  </div>
</div>

  </div>
</div>

<div class="row breadcrumbs-wrapper ">
  <div class="col-xs-12 col-md-12 breadcrumb-nav" data-hierarchy="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;D&quot;,&quot;part&quot;:&quot;314&quot;,&quot;subpart&quot;:&quot;B&quot;,&quot;section&quot;:&quot;314.81&quot;}" data-filtered-search-enabled="false">
    <div class='row'>
      <div class="col-xs-12 col-md-9">
        <ol>
    <li class="">
        <a class="breadcrumb-link" data-toggle="tooltip" data-placement="top" data-title="View Table of Contents for Title 21—Food and Drugs" href="/current/title-21">Title 21 <span class="print-only breadcrumbs-title" data-hierarchy="{'title':'21'}">—Food and Drugs</span></a>
    </li>
    <li class="">
        <a class="breadcrumb-link" data-toggle="tooltip" data-placement="top" data-title="View Table of Contents for  Chapter I—Food and Drug Administration, Department of Health and Human Services" href="/current/title-21/chapter-I"> Chapter I <span class="print-only breadcrumbs-title" data-hierarchy="{'title':'21','chapter':'I'}">—Food and Drug Administration, Department of Health and Human Services</span></a>
    </li>
    <li class="">
        <a class="breadcrumb-link" data-toggle="tooltip" data-placement="top" data-title="View Table of Contents for Subchapter D—Drugs for Human Use" href="/current/title-21/chapter-I/subchapter-D">Subchapter D <span class="print-only breadcrumbs-title" data-hierarchy="{'title':'21','chapter':'I','subchapter':'D'}">—Drugs for Human Use</span></a>
    </li>
    <li class="">
        <a class="breadcrumb-link" data-toggle="tooltip" data-placement="top" data-title="View Table of Contents for Part 314—Applications for FDA Approval to Market a New Drug" href="/current/title-21/chapter-I/subchapter-D/part-314?toc=1">Part 314 <span class="print-only breadcrumbs-title" data-hierarchy="{'title':'21','chapter':'I','subchapter':'D','part':'314'}">—Applications for FDA Approval to Market a New Drug</span></a>
    </li>
    <li class="">
        <a class="breadcrumb-link" data-toggle="tooltip" data-placement="top" data-title="View Table of Contents for Subpart B—Applications" href="/current/title-21/chapter-I/subchapter-D/part-314/subpart-B?toc=1">Subpart B <span class="print-only breadcrumbs-title" data-hierarchy="{'title':'21','chapter':'I','subchapter':'D','part':'314','subpart':'B'}">—Applications</span></a>
    </li>
    <li class="breadcrumb-current">
        § 314.81

    </li>
</ol>

      </div>

      <div class="col-xs-12 col-md-3 text-right">
        <ul class="prev-next-breadcrumb-nav">
  <li>
      <a id="previous-content-link" data-title="§ 314.80 Postmarketing reporting of adverse drug experiences." data-html="true" href="/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.80">Previous</a>
  </li>

  <li>
      <a id="next-content-link" data-title="§ 314.90 Waivers." data-html="true" href="/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.90">Next</a>
  </li>

  <li id="breadcrumb-back-to-top">
    <a data-title="Back to Top" data-turbo="false" href="#page-top">Top</a>
  </li>
</ul>

      </div>
    </div>
</div></div>


<div class="row ecfr-content-wrapper">
  <div class="col-xs-12 col-md-12 ecfr-content with-utility-bar">
    <div class="row">
      <div class="col-xs-3 col-sm-2 content-nav-wrapper content-nav-wrapper-wide">
        
<ul class="content-nav text-center dropdown drop-enhanced ui sticky">
  <li class="button">
    <span role="button" arial-label="compress content nav" class="icon-ecfr icon-ecfr-previous-media content-nav-compress-toggle"></span>
  </li>

  

<li class="inactive " id="utility-nav-toc" tabindex="0"><span role="button" aria-label="Table of Contents" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Table of Contents" class="icon-ecfr icon-ecfr-book "></span><span class="content-nav-label " role="button">Table of Contents</span><div class="box box-enhanced box-enhanced-toc box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Table of Contents</h6></div></div><div class="content-block ">      <p>
        The in-page Table of Contents is available only when multiple sections are being viewed.
      </p>
      <p>
        Use the navigation links in the gray bar above to view the table of contents that this content belongs to.
      </p>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Table of Contents</h6></div></div></li>

  
<li class="enhanced " id="utility-nav-details" tabindex="0"><span role="button" aria-label="Details" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Details" class="icon-ecfr icon-ecfr-book-alt-2 "></span><span class="content-nav-label " role="button">Details</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Details</h6></div></div><div class="content-block ">    <dl class="">
      <dt>URL</dt>
      <dd>
        https://www.ecfr.gov/current/title-21/part-314/section-314.81
        <span data-toggle="tooltip" data-title="Copy to Clipboard" class="svg-tooltip copy-to-clipboard" data-title-copied="Copied to Clipboard" data-copy-text="https://www.ecfr.gov/current/title-21/part-314/section-314.81"><svg class="ecfr-svg-icon ecfr-svg-icon-content-copy "><use xlink:href="/assets/ecfr-icons-c08c495b1eda093da23b5b159c24927a91aa7c13df40f52ca7d30476904de0ea.svg#ecfr-svg-icon-content-copy"></use></svg></span>
      </dd>

        <dt>Citation</dt>
        <dd>
          21 CFR 314.81
          <span data-toggle="tooltip" data-title="Copy to Clipboard" class="svg-tooltip copy-to-clipboard" data-title-copied="Copied to Clipboard" data-copy-text="21 CFR 314.81"><svg class="ecfr-svg-icon ecfr-svg-icon-content-copy "><use xlink:href="/assets/ecfr-icons-c08c495b1eda093da23b5b159c24927a91aa7c13df40f52ca7d30476904de0ea.svg#ecfr-svg-icon-content-copy"></use></svg></span>
        </dd>



        <dt>
          Agency
          <span data-toggle="tooltip" data-title="The agency currently associated with this eCFR content. Click for more details." class="svg-tooltip clickable" data-url="/reader-aids/using-ecfr/agency-references#details_sidebar" data-container="dl"><svg class="ecfr-svg-icon ecfr-svg-icon-info-circle "><use xlink:href="/assets/ecfr-icons-c08c495b1eda093da23b5b159c24927a91aa7c13df40f52ca7d30476904de0ea.svg#ecfr-svg-icon-info-circle"></use></svg></span>
        </dt>
          <dd data-issuing-agency=food-and-drug-administration>Food and Drug Administration, Department of Health and Human Services</dd>
    </dl>

    <hr>

    <div id="source-and-authority">
        <div class="additional-source-and-authority">
      <div class="level">
        <a href="/current/title-21/part-314" class="cfr reference">Part 314</a>
        <div class="details" data-hierarchy="{:title=&gt;&quot;21&quot;, :chapter=&gt;&quot;I&quot;, :subchapter=&gt;&quot;D&quot;, :part=&gt;&quot;314&quot;}" data-current="false">
            <div class="authority">
              <h4 class="inline-header">Authority:</h4>
              <p class="inline-paragraph">
                <a href="https://www.govinfo.gov/link/uscode/21/321" class="usc external" target="_blank" rel="noopener noreferrer">21 U.S.C. 321</a>, <a href="https://www.govinfo.gov/link/uscode/21/331" class="usc external" target="_blank" rel="noopener noreferrer">331</a>, <a href="https://www.govinfo.gov/link/uscode/21/351" class="usc external" target="_blank" rel="noopener noreferrer">351</a>, <a href="https://www.govinfo.gov/link/uscode/21/352" class="usc external" target="_blank" rel="noopener noreferrer">352</a>, <a href="https://www.govinfo.gov/link/uscode/21/353" class="usc external" target="_blank" rel="noopener noreferrer">353</a>, <a href="https://www.govinfo.gov/link/uscode/21/355" class="usc external" target="_blank" rel="noopener noreferrer">355</a>, <a href="https://www.govinfo.gov/link/uscode/21/355a" class="usc external" target="_blank" rel="noopener noreferrer">355a</a>, <a href="https://www.govinfo.gov/link/uscode/21/355f" class="usc external" target="_blank" rel="noopener noreferrer">355f</a>, <a href="https://www.govinfo.gov/link/uscode/21/356" class="usc external" target="_blank" rel="noopener noreferrer">356</a>, <a href="https://www.govinfo.gov/link/uscode/21/356a" class="usc external" target="_blank" rel="noopener noreferrer">356a</a>, <a href="https://www.govinfo.gov/link/uscode/21/356b" class="usc external" target="_blank" rel="noopener noreferrer">356b</a>, <a href="https://www.govinfo.gov/link/uscode/21/356c" class="usc external" target="_blank" rel="noopener noreferrer">356c</a>, <a href="https://www.govinfo.gov/link/uscode/21/356e" class="usc external" target="_blank" rel="noopener noreferrer">356e</a>, <a href="https://www.govinfo.gov/link/uscode/21/360cc" class="usc external" target="_blank" rel="noopener noreferrer">360cc</a>, <a href="https://www.govinfo.gov/link/uscode/21/371" class="usc external" target="_blank" rel="noopener noreferrer">371</a>, <a href="https://www.govinfo.gov/link/uscode/21/374" class="usc external" target="_blank" rel="noopener noreferrer">374</a>, <a href="https://www.govinfo.gov/link/uscode/21/379e" class="usc external" target="_blank" rel="noopener noreferrer">379e</a>, <a href="https://www.govinfo.gov/link/uscode/21/379k-1" class="usc external" target="_blank" rel="noopener noreferrer">379k-1</a>.


              </p>
            </div>
            <div class="source">
              <h4 class="inline-header">Source:</h4>
              <p class="inline-paragraph">
                <a href="https://www.federalregister.gov/citation/50-FR-7493" class="fr-reference" data-reference="50 FR 7493">50 FR 7493</a>, Feb. 22, 1985, unless otherwise noted.


              </p>
            </div>
        </div>
      </div>
  </div>

    </div>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Details</h6></div></div></li>

  
<li class="enhanced " id="" tabindex="0"><span role="button" aria-label="Print/PDF" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Print/PDF" class="icon-ecfr icon-ecfr-print "></span><span class="content-nav-label " role="button">Print/PDF</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Print</h6></div></div><div class="content-block ">      <p>
        <a class="generate-pdf" data-original-text="Generate PDF <small class=&quot;text-warning&quot;>(approximately 10+ pages)</small>" href="#">Generate PDF <small class="text-warning">(approximately 10+ pages)</small></a>

        <span class="pdf-spinner" style="display:none;">
          <span class="spinner"></span>
        </span>
      </p>
      <p>
        This content is from the eCFR and may include recent changes applied to the CFR.
        The official, published CFR, is updated annually and available below under
        "Published Edition". You can learn more about the process
        <a href="https://www.govinfo.gov/help/cfr#about">here</a>.
      </p>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Print</h6></div></div></li>

  
<li class="enhanced " id="" tabindex="0"><span role="button" aria-label="Display Options" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Display Options" class="icon-ecfr icon-ecfr-doc-generic "></span><span class="content-nav-label " role="button">Display Options</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Display Options</h6></div></div><div class="content-block ">    <turbo-frame id="side_display" src="/display/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81" loading="lazy">
      <span class="timeline-spinner">
        <span class="spinner"></span>
      </span>
    </turbo-frame>  
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Display Options</h6></div></div></li>

  
<li class="enhanced utility-nav-subscribe" id="utility-nav-subscribe" tabindex="0"><span role="button" aria-label="Subscribe" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Subscribe" class="icon-ecfr icon-ecfr-message "></span><span class="content-nav-label " role="button">Subscribe</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Subscribe</h6></div></div><div class="content-block ">    <p><strong>Subscribe to:</strong> 21 CFR 314.81</p>

    <div class="subscription-option">
      <form class="simple_form form-horizontal subscribe" id="new_subscription" data-turbo="false" novalidate="novalidate" action="/my/subscriptions" accept-charset="UTF-8" method="post">
            <div class="form-group hidden subscription_title"><input class="form-control hidden hierarchy-input" value="21" name="search[hierarchy][title]" autocomplete="off" type="hidden" id="subscription_title" /></div>
            <div class="form-group hidden subscription_chapter"><input class="form-control hidden hierarchy-input" value="I" name="search[hierarchy][chapter]" autocomplete="off" type="hidden" id="subscription_chapter" /></div>
            <div class="form-group hidden subscription_subchapter"><input class="form-control hidden hierarchy-input" value="D" name="search[hierarchy][subchapter]" autocomplete="off" type="hidden" id="subscription_subchapter" /></div>
            <div class="form-group hidden subscription_part"><input class="form-control hidden hierarchy-input" value="314" name="search[hierarchy][part]" autocomplete="off" type="hidden" id="subscription_part" /></div>
            <div class="form-group hidden subscription_subpart"><input class="form-control hidden hierarchy-input" value="B" name="search[hierarchy][subpart]" autocomplete="off" type="hidden" id="subscription_subpart" /></div>
            <div class="form-group hidden subscription_section"><input class="form-control hidden hierarchy-input" value="314.81" name="search[hierarchy][section]" autocomplete="off" type="hidden" id="subscription_section" /></div>

        <div class="subscription-option">
          <span class="icon-ecfr icon-ecfr-message "></span><label class='email-label'>Via Email:</label>
          <input type="submit" name="commit" value="Subscribe" class="btn-as-link" data-disable-with="Subscribe" />
        </div>

        <!-- <div class="subscription-option"> -->
          <!-- <label class='rss-label'>Via RSS:</label> -->

        <!-- </div> -->
</form>    </div>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Subscribe</h6></div></div></li>

  <li class="divider"></li>

    
<li class="enhanced " id="utility-nav-timeline" tabindex="0"><span role="button" aria-label="Timeline" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Timeline" class="icon-ecfr icon-ecfr-hourglass "></span><span class="content-nav-label " role="button">Timeline</span><div class="box box-enhanced box-enhanced-timeline box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Timeline</h6></div></div><div class="content-block ">
        <turbo-frame data-controller="timeline" id="side_timeline" target="_top">
      <ol class="timeline list with-bullets enhanced">
          <li>
            <span class='date current-change'>
              3/25/2025
            </span>

            <span class='timeline'>
              <a href="/on/2025-03-25/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81">view on this date</a>
            </span>

            <span class='timeline'>
              <a data-diff-path="/compare/2025-03-25/to/2025-03-24/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81" href="#">view change <span class="hidden-xs hidden-sm">introduced</span></a>
            </span>

              <span class='timeline'>&nbsp;</span>
          </li>
          <li>
            <span class='date'>
              1/27/2025
            </span>

            <span class='timeline'>
              <a href="/on/2025-01-27/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81">view on this date</a>
            </span>

            <span class='timeline'>
              <a data-diff-path="/compare/2025-01-27/to/2025-01-26/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81" href="#">view change <span class="hidden-xs hidden-sm">introduced</span></a>
            </span>

              <span class='timeline'><a data-diff-path="/compare/current/to/2025-01-27/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81" href="#">compare to most recent</a></span>
          </li>
          <li>
            <span class='date'>
              12/26/2024
            </span>

            <span class='timeline'>
              <a href="/on/2024-12-26/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81">view on this date</a>
            </span>

            <span class='timeline'>
              <a data-diff-path="/compare/2024-12-26/to/2024-12-25/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81" href="#">view change <span class="hidden-xs hidden-sm">introduced</span></a>
            </span>

              <span class='timeline'><a data-diff-path="/compare/current/to/2024-12-26/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81" href="#">compare to most recent</a></span>
          </li>
      </ol>
</turbo-frame>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Timeline</h6></div></div></li>

  
<li class="enhanced " id="utility-nav-go-to-date" tabindex="0"><span role="button" aria-label="Go to Date" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Go to Date" class="icon-ecfr icon-ecfr-calendar-alt "></span><span class="content-nav-label " role="button">Go to Date</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Go to Date</h6></div></div><div class="content-block ">    <form class="simple_form form-horizontal go-to-date" id="go-to-date-form" autocomplete="off" novalidate="novalidate" action="#" accept-charset="UTF-8" method="get">

      <div class="form-group bootstrap_datepicker optional go_to_date_date"><label class="control-label bootstrap_datepicker optional" for="go_to_date_date">Date</label><div class='input-group'>
<input class="form-control bootstrap_datepicker optional bootstrap-datepicker" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" type="text" name="go_to_date[date_box]" id="go_to_date_date_box" />
<span class='input-group-addon calendar-btn'><span class='glyphicon glyphicon-calendar'></span></span>
</div>
<input class="form-control bootstrap_datepicker optional" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" id="date_hidden" value="" autocomplete="off" type="hidden" name="go_to_date[date]" />
</div>

      <input type="submit" name="commit" value="Go to date" class="btn btn-default btn btn-primary-alt btn-medium" data-disable-with="Go to date" />
</form>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Go to Date</h6></div></div></li>

  

<li class="enhanced " id="utility-nav-compare" tabindex="0"><span role="button" aria-label="Compare Dates" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Compare Dates" class="icon-ecfr icon-ecfr-forking "></span><span class="content-nav-label " role="button">Compare Dates</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Compare Dates</h6></div></div><div class="content-block ">      <form class="simple_form form-horizontal compare-content" id="new_compare" autocomplete="off" novalidate="novalidate" action="/compare" accept-charset="UTF-8" method="post">

        <div class="form-group bootstrap_datepicker optional compare_from"><label class="control-label bootstrap_datepicker optional" for="compare_from">Compare</label><div class='input-group'>
<input class="form-control bootstrap_datepicker optional bootstrap-datepicker" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" type="text" name="compare[from_box]" id="compare_from_box" />
<span class='input-group-addon calendar-btn'><span class='glyphicon glyphicon-calendar'></span></span>
</div>
<input class="form-control bootstrap_datepicker optional" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" id="from_hidden" value="" autocomplete="off" type="hidden" name="compare[from]" />
</div>

        <div class="form-group bootstrap_datepicker optional compare_to"><label class="control-label bootstrap_datepicker optional" for="compare_to">to</label><div class='input-group'>
<input class="form-control bootstrap_datepicker optional bootstrap-datepicker" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" type="text" value="04/20/2025" name="compare[to_box]" id="compare_to_box" />
<span class='input-group-addon calendar-btn'><span class='glyphicon glyphicon-calendar'></span></span>
</div>
<input class="form-control bootstrap_datepicker optional" data-date-start-date="1/03/2017" data-date-force-parse="false" data-date-assume-nearby-year="true" data-date-format="mm/dd/yyyy" data-date-autoclose="true" data-provide="datepicker" id="to_hidden" value="2025-04-20" autocomplete="off" type="hidden" name="compare[to]" />
</div>

        <div class="form-group hidden compare_hierarchy"><input class="form-control hidden" autocomplete="off" type="hidden" value="{&quot;title&quot;:&quot;21&quot;,&quot;chapter&quot;:&quot;I&quot;,&quot;subchapter&quot;:&quot;D&quot;,&quot;part&quot;:&quot;314&quot;,&quot;subpart&quot;:&quot;B&quot;,&quot;section&quot;:&quot;314.81&quot;,&quot;complete&quot;:true}" name="compare[hierarchy]" id="compare_hierarchy" /></div>
        <div class="form-group hidden compare_view_mode"><input class="form-control hidden" autocomplete="off" type="hidden" name="compare[view_mode]" id="compare_view_mode" /></div>

        <input type="submit" name="commit" value="Compare Dates" class="btn btn-default btn btn-primary-alt btn-medium" data-disable-with="Compare Dates" />
</form>
      <form class="simple_form compare-style-choices" id="new_compare_style_choices" novalidate="novalidate" action="#" accept-charset="UTF-8" method="get">
        <div class="form-group radio_buttons optional compare_style_choices_diff_color"><label class="control-label radio_buttons optional">Show changes as:</label><span class="radio"><label for="compare_style_choices_diff_color_rg-diff"><input class="radio_buttons optional" type="radio" value="rg-diff" checked="checked" name="compare_style_choices[diff_color]" id="compare_style_choices_diff_color_rg-diff" />red/green</label></span><span class="radio"><label for="compare_style_choices_diff_color_po-diff"><input class="radio_buttons optional" type="radio" value="po-diff" name="compare_style_choices[diff_color]" id="compare_style_choices_diff_color_po-diff" />purple/orange</label></span></div>

        <div class="form-group radio_buttons optional compare_style_choices_strikethrough"><label class="control-label radio_buttons optional">Show strike-through for removed content</label><span class="radio"><label for="compare_style_choices_strikethrough_true"><input class="radio_buttons optional" type="radio" value="true" checked="checked" name="compare_style_choices[strikethrough]" id="compare_style_choices_strikethrough_true" />yes</label></span><span class="radio"><label for="compare_style_choices_strikethrough_false"><input class="radio_buttons optional" readonly="readonly" type="radio" value="false" name="compare_style_choices[strikethrough]" id="compare_style_choices_strikethrough_false" />no</label></span></div>
</form></div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Compare Dates</h6></div></div></li>

  <li class="divider"></li>

  
<li class="enhanced published-edition" id="" tabindex="0"><span role="button" aria-label="Published Edition" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Published Edition" class="icon-ecfr icon-ecfr-doc-pdf "></span><span class="content-nav-label " role="button">Published Edition</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Published Edition</h6></div></div><div class="content-block ">    <p>
      View the most recent official publication:
    </p>

    <ul class="list with-bullets enhanced">
        <li>
          <a data-turbo="false" href="https://www.govinfo.gov/app/collection/cfr/2025">View Title 21 on govinfo.gov</a>
        </li>
        <li>
          <a data-turbo="false" href="https://www.govinfo.gov/link/cfr/21/314?link-type=pdf&amp;sectionnum=81&amp;year=mostrecent">View the PDF for 21 CFR 314.81</a>
        </li>
    </ul>

    <p>
      These links go to the official, published CFR, which is updated annually. As a
      result, it may not include the most recent changes applied to the CFR.
      <a href="https://www.govinfo.gov/help/cfr#about">Learn more</a>.
    </p>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Published Edition</h6></div></div></li>

  <li class="divider"></li>

  
<li class="enhanced developer-tools" id="" tabindex="0"><span role="button" aria-label="Developer Tools" data-delay="{&quot;show&quot;:300,&quot;hide&quot;:0}" data-toggle="tooltip" data-placement="top" data-title="Developer Tools" class="icon-ecfr icon-ecfr-console "></span><span class="content-nav-label " role="button">Developer Tools</span><div class="box box-enhanced box-full dropdown-menu dropdown-menu-right" role="menu"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Enhanced Content - Developer Tools</h6></div></div><div class="content-block ">
      <turbo-frame id="side_developer" src="/developer/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81" loading="lazy">
        <span class="timeline-spinner">
          <span class="spinner"></span>
        </span>
        <br/><br/>
      </turbo-frame>

    <p>
      Information and documentation can be found in our
      <a href="/reader-aids/ecfr-developer-resources">developer resources</a>.
    </p>
</div><div class="seal-block seal-block-footer"><h6>Enhanced Content - Developer Tools</h6></div></div></li>
</ul>

      </div>

      <div class="col-xs-9 col-sm-10 content-col">
        <div class="box box-published no-print-header compare-settings"><div class="seal-block seal-block-header"><div class="seal-content"><h6>eCFR Content</h6><div class="row seal-meta"><div class="seal-desc col-md-12 col-xs-12"><p><p>The <em>Code of Federal Regulations</em> (CFR) is the official legal print publication containing the codification of the general and permanent rules published in the <em>Federal Register</em> by the departments and agencies of the Federal Government. The Electronic Code of Federal Regulations (eCFR) is a continuously updated online version of the CFR. It is not an official legal edition of the CFR.</p> <p><a href='/reader-aids/understanding-the-ecfr/what-is-the-ecfr'>Learn more</a> about the eCFR, its status, and the editorial process.<p></p></div></div></div></div><div class="content-block leaf">

          <div class="editorial-note"><div class="box box-published no-footer"><div class="seal-block seal-block-header"><div class="seal-content"><h6>Editorial Note on <a href="/current/title-21/part-314?toc=1">Part 314</a></h6></div></div><div class="content-block "><h4 class="inline-header">Editorial Note:</h4>
<p class="inline-paragraph">Nomenclature changes to part 314 appear at <a href="https://www.federalregister.gov/citation/69-FR-13717" class="fr-reference" data-reference="69 FR 13717">69 FR 13717</a>, Mar. 24, 2004; <a href="https://www.federalregister.gov/citation/81-FR-69639" class="fr-reference" data-reference="81 FR 69639">81 FR 69639</a>, Oct. 6, 2016.</p></div></div></div><div class="section" id="314.81">
<h4 data-hierarchy-metadata='{"path":"/current/title-21/section-314.81","citation":"21 CFR 314.81"}'>§ 314.81 Other postmarketing reports.</h4>
<div class="fr-cross-reference"><div class="box box-enhanced no-footer">
<div class="seal-block seal-block-header"><div class="seal-content"><h6>Cross Reference</h6></div></div>
<div class="content-block ">Link to an amendment published at <a href="https://www.federalregister.gov/citation/89-FR-105331" class="fr-reference" data-reference="89 FR 105331">89 FR 105331</a>, Dec. 26, 2024.</div>
</div></div>
<div class="fr-cross-reference"><div class="box box-enhanced no-footer">
<div class="seal-block seal-block-header"><div class="seal-content"><h6>Cross Reference</h6></div></div>
<div class="content-block ">This amendment was delayed until Mar. 21, 2025, at <a href="https://www.federalregister.gov/citation/90-FR-8173" class="fr-reference" data-reference="90 FR 8173">90 FR 8173</a>, Jan. 27, 2025.</div>
</div></div>
<div class="fr-cross-reference"><div class="box box-enhanced no-footer">
<div class="seal-block seal-block-header"><div class="seal-content"><h6>Cross Reference</h6></div></div>
<div class="content-block ">This amendment was further delayed until May 27, 2025, at <a href="https://www.federalregister.gov/citation/90-FR-13553" class="fr-reference" data-reference="90 FR 13553">90 FR 13553</a>, Mar. 25, 2025.</div>
</div></div>
<div id="p-314.81(a)">
<p class="indent-1" data-title="314.81(a)"><span class="paragraph-hierarchy"><span class="paren">(</span>a<span class="paren">)</span></span> <em class="paragraph-heading">Applicability.</em>  Each applicant shall make the reports for each of its approved applications and abbreviated applications required under this section and section 505(k) of the act.</p>
</div>
<div id="p-314.81(b)">
<p class="indent-1" data-title="314.81(b)"><span class="paragraph-hierarchy"><span class="paren">(</span>b<span class="paren">)</span></span> <em class="paragraph-heading">Reporting requirements.</em>  The applicant shall submit to the Food and Drug Administration at the specified times two copies of the following reports:</p>
<div id="p-314.81(b)(1)">
<p class="indent-2" data-title="314.81(b)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> <em class="paragraph-heading">NDA—Field alert report.</em>  The applicant shall submit information of the following kinds about distributed drug products and articles to the FDA district office that is responsible for the facility involved within 3 working days of receipt by the applicant. The information may be provided by telephone or other rapid communication means, with prompt written followup. The report and its mailing cover should be plainly marked: “NDA—Field Alert Report.”</p>
<div id="p-314.81(b)(1)(i)">
<p class="indent-3" data-title="314.81(b)(1)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> Information concerning any incident that causes the drug product or its labeling to be mistaken for, or applied to, another article.</p>
</div>
<div id="p-314.81(b)(1)(ii)">
<p class="indent-3" data-title="314.81(b)(1)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> Information concerning any bacteriological contamination, or any significant chemical, physical, or other change or deterioration in the distributed drug product, or any failure of one or more distributed batches of the drug product to meet the specification established for it in the application.</p>
</div>
</div>
<div id="p-314.81(b)(2)">
<p class="indent-2" data-title="314.81(b)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> <em class="paragraph-heading">Annual report.</em>  The applicant shall submit each year within 60 days of the anniversary date of U.S. approval of the application, two copies of the report to the FDA division responsible for reviewing the application. Each annual report is required to be accompanied by a completed transmittal Form FDA 2252 (Transmittal of Periodic Reports for Drugs for Human Use), and must include all the information required under this section that the applicant received or otherwise obtained during the annual reporting interval that ends on the U.S. anniversary date. The report is required to contain in the order listed:</p>
<div id="p-314.81(b)(2)(i)">
<p class="indent-3" data-title="314.81(b)(2)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> <em class="paragraph-heading">Summary.</em>  A brief summary of significant new information from the previous year that might affect the safety, effectiveness, or labeling of the drug product. The report is also required to contain a brief description of actions the applicant has taken or intends to take as a result of this new information, for example, submit a labeling supplement, add a warning to the labeling, or initiate a new study. The summary shall briefly state whether labeling supplements for pediatric use have been submitted and whether new studies in the pediatric population to support appropriate labeling for the pediatric population have been initiated. Where possible, an estimate of patient exposure to the drug product, with special reference to the pediatric population (neonates, infants, children, and adolescents) shall be provided, including dosage form.</p>
</div>
<div id="p-314.81(b)(2)(ii)">
<p class="indent-3" data-title="314.81(b)(2)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> </p>
<div id="p-314.81(b)(2)(ii)(a)">
<p class="indent-4" data-title="314.81(b)(2)(ii)(&lt;em&gt;a&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>a</em><span class="paren">)</span></span> <em class="paragraph-heading">Distribution data.</em>  Information about the quantity of the drug product distributed under the approved application, including that distributed to distributors. The information is required to include the National Drug Code (NDC) number, the total number of dosage units of each strength or potency distributed (e.g., 100,000/5 milligram tablets, 50,000/10 milliliter vials), and the quantities distributed for domestic use and the quantities distributed for foreign use. Disclosure of financial or pricing data is not required.</p>
</div>
<div id="p-314.81(b)(2)(ii)(b)">
<p class="indent-4" data-title="314.81(b)(2)(ii)(&lt;em&gt;b&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>b</em><span class="paren">)</span></span> <em class="paragraph-heading">Authorized generic drugs.</em>  If applicable, the date each authorized generic drug (as defined in <a href="/current/title-21/section-314.3" class="cfr external">§ 314.3</a>) entered the market, the date each authorized generic drug ceased being distributed, and the corresponding trade or brand name. Each dosage form and/or strength is a different authorized generic drug and should be listed separately. The first annual report submitted on or after January 25, 2010 must include the information listed in this paragraph for any authorized generic drug that was marketed during the time period covered by an annual report submitted after January 1, 1999. If information is included in the annual report with respect to any authorized generic drug, a copy of that portion of the annual report must be sent to the Food and Drug Administration, Center for Drug Evaluation and Research, Office of New Drug Quality Assessment, Bldg. 21, rm. 2562, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, and marked “Authorized Generic Submission” or, by e-mail, to the Authorized Generics electronic mailbox at <em><a href="mailto:AuthorizedGenerics@fda.hhs.gov" class="email">AuthorizedGenerics@fda.hhs.gov</a></em> with “Authorized Generic Submission” indicated in the subject line. However, at such time that FDA has required that annual reports be submitted in an electronic format, the information required by this paragraph must be submitted as part of the annual report, in the electronic format specified for submission of annual reports at that time, and not as a separate submission under the preceding sentence in this paragraph.</p>
</div>
</div>
<div id="p-314.81(b)(2)(iii)">
<p class="indent-3" data-title="314.81(b)(2)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> <em class="paragraph-heading">Labeling.</em> </p>
<div id="p-314.81(b)(2)(iii)(a)">
<p class="indent-4" data-title="314.81(b)(2)(iii)(&lt;em&gt;a&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>a</em><span class="paren">)</span></span> Currently used professional labeling, patient brochures or package inserts (if any), and a representative sample of the package labels.</p>
</div>
<div id="p-314.81(b)(2)(iii)(b)">
<p class="indent-4" data-title="314.81(b)(2)(iii)(&lt;em&gt;b&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>b</em><span class="paren">)</span></span> The content of labeling required under <a href="/current/title-21/section-201.100#p-201.100(d)(3)" class="cfr external">§ 201.100(d)(3) of this chapter</a> (<em>i.e.</em>, the package insert or professional labeling), including all text, tables, and figures, must be submitted in electronic format. Electronic format submissions must be in a form that FDA can process, review, and archive. FDA will periodically issue guidance on how to provide the electronic submission (e.g., method of transmission, media, file formats, preparation and organization of files). Submissions under this paragraph must be made in accordance with <a href="/current/title-21/part-11" class="cfr external">part 11 of this chapter</a>, except for the requirements of <a href="/current/title-21/section-11.10#p-11.10(a)" class="cfr external">§ 11.10(a)</a>, <a href="/current/title-21/section-11.10#p-11.10(c)" class="cfr external">(c)</a> through <a href="/current/title-21/section-11.10#p-11.10(h)" class="cfr external">(h)</a>, and <a href="/current/title-21/section-11.10#p-11.10(k)" class="cfr external">(k)</a>, and the corresponding requirements of <a href="/current/title-21/section-11.30" class="cfr external">§ 11.30</a>.</p>
</div>
<div id="p-314.81(b)(2)(iii)(c)">
<p class="indent-4" data-title="314.81(b)(2)(iii)(&lt;em&gt;c&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>c</em><span class="paren">)</span></span> A summary of any changes in labeling that have been made since the last report listed by date in the order in which they were implemented, or if no changes, a statement of that fact.</p>
</div>
</div>
<div id="p-314.81(b)(2)(iv)">
<p class="indent-3" data-title="314.81(b)(2)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> <em class="paragraph-heading">Chemistry, manufacturing, and controls changes.</em> </p>
<div id="p-314.81(b)(2)(iv)(a)">
<p class="indent-4" data-title="314.81(b)(2)(iv)(&lt;em&gt;a&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>a</em><span class="paren">)</span></span> Reports of experiences, investigations, studies, or tests involving chemical or physical properties, or any other properties of the drug (such as the drug's behavior or properties in relation to microorganisms, including both the effects of the drug on microorganisms and the effects of microorganisms on the drug). These reports are only required for new information that may affect FDA's previous conclusions about the safety or effectiveness of the drug product.</p>
</div>
<div id="p-314.81(b)(2)(iv)(b)">
<p class="indent-4" data-title="314.81(b)(2)(iv)(&lt;em&gt;b&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>b</em><span class="paren">)</span></span> A full description of the manufacturing and controls changes not requiring a supplemental application under <a href="/current/title-21/section-314.70#p-314.70(b)" class="cfr external">§ 314.70 (b)</a> and <a href="/current/title-21/section-314.70#p-314.70(c)" class="cfr external">(c)</a>, listed by date in the order in which they were implemented.</p>
</div>
</div>
<div id="p-314.81(b)(2)(v)">
<p class="indent-3" data-title="314.81(b)(2)(v)"><span class="paragraph-hierarchy"><span class="paren">(</span>v<span class="paren">)</span></span> <em class="paragraph-heading">Nonclinical laboratory studies.</em>  Copies of unpublished reports and summaries of published reports of new toxicological findings in animal studies and in vitro studies (e.g., mutagenicity) conducted by, or otherwise obtained by, the applicant concerning the ingredients in the drug product. The applicant shall submit a copy of a published report if requested by FDA.</p>
</div>
<div id="p-314.81(b)(2)(vi)">
<p class="indent-3" data-title="314.81(b)(2)(vi)"><span class="paragraph-hierarchy"><span class="paren">(</span>vi<span class="paren">)</span></span> <em class="paragraph-heading">Clinical data.</em> </p>
<div id="p-314.81(b)(2)(vi)(a)">
<p class="indent-4" data-title="314.81(b)(2)(vi)(&lt;em&gt;a&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>a</em><span class="paren">)</span></span> Published clinical trials of the drug (or abstracts of them), including clinical trials on safety and effectiveness; clinical trials on new uses; biopharmaceutic, pharmacokinetic, and clinical pharmacology studies; and reports of clinical experience pertinent to safety (for example, epidemiologic studies or analyses of experience in a monitored series of patients) conducted by or otherwise obtained by the applicant. Review articles, papers describing the use of the drug product in medical practice, papers and abstracts in which the drug is used as a research tool, promotional articles, press clippings, and papers that do not contain tabulations or summaries of original data should not be reported.</p>
</div>
<div id="p-314.81(b)(2)(vi)(b)">
<p class="indent-4" data-title="314.81(b)(2)(vi)(&lt;em&gt;b&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>b</em><span class="paren">)</span></span> Summaries of completed unpublished clinical trials, or prepublication manuscripts if available, conducted by, or otherwise obtained by, the applicant. Supporting information should not be reported. (A study is considered completed 1 year after it is concluded.)</p>
</div>
<div id="p-314.81(b)(2)(vi)(c)">
<p class="indent-4" data-title="314.81(b)(2)(vi)(&lt;em&gt;c&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>c</em><span class="paren">)</span></span> Analysis of available safety and efficacy data in the pediatric population and changes proposed in the labeling based on this information. An assessment of data needed to ensure appropriate labeling for the pediatric population shall be included.</p>
</div>
</div>
<div id="p-314.81(b)(2)(vii)">
<p class="indent-3" data-title="314.81(b)(2)(vii)"><span class="paragraph-hierarchy"><span class="paren">(</span>vii<span class="paren">)</span></span> <em class="paragraph-heading">Status reports of postmarketing study commitments.</em>  A status report of each postmarketing study of the drug product concerning clinical safety, clinical efficacy, clinical pharmacology, and nonclinical toxicology that is required by FDA (e.g., accelerated approval clinical benefit studies, pediatric studies) or that the applicant has committed, in writing, to conduct either at the time of approval of an application for the drug product or a supplement to an application, or after approval of the application or a supplement. For pediatric studies, the status report shall include a statement indicating whether postmarketing clinical studies in pediatric populations were required by FDA under <a href="/current/title-21/section-201.23" class="cfr external">§ 201.23 of this chapter</a>. The status of these postmarketing studies shall be reported annually until FDA notifies the applicant, in writing, that the agency concurs with the applicant's determination that the study commitment has been fulfilled or that the study is either no longer feasible or would no longer provide useful information.</p>
<div id="p-314.81(b)(2)(vii)(a)">
<p class="indent-4" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>a</em><span class="paren">)</span></span> <em class="paragraph-heading">Content of status report.</em>  The following information must be provided for each postmarketing study reported under this paragraph:</p>
<div id="p-314.81(b)(2)(vii)(a)(1)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>1</em><span class="paren">)</span></span> <em class="paragraph-heading">Applicant's name.</em> </p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(2)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;2&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>2</em><span class="paren">)</span></span> <em class="paragraph-heading">Product name.</em>  Include the approved drug product's established name and proprietary name, if any.</p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(3)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;3&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>3</em><span class="paren">)</span></span> <em class="paragraph-heading">NDA, ANDA, and supplement number.</em> </p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(4)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;4&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>4</em><span class="paren">)</span></span> <em class="paragraph-heading">Date of U.S. approval of NDA or ANDA.</em> </p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(5)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;5&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>5</em><span class="paren">)</span></span> <em class="paragraph-heading">Date of postmarketing study commitment.</em> </p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(6)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;6&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>6</em><span class="paren">)</span></span> <em class="paragraph-heading">Description of postmarketing study commitment.</em>  The description must include sufficient information to uniquely describe the study. This information may include the purpose of the study, the type of study, the patient population addressed by the study and the indication(s) and dosage(s) that are to be studied.</p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(7)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;7&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>7</em><span class="paren">)</span></span> <em class="paragraph-heading">Schedule for completion and reporting of the postmarketing study commitment.</em>  The schedule should include the actual or projected dates for submission of the study protocol to FDA, completion of patient accrual or initiation of an animal study, completion of the study, submission of the final study report to FDA, and any additional milestones or submissions for which projected dates were specified as part of the commitment. In addition, it should include a revised schedule, as appropriate. If the schedule has been previously revised, provide both the original schedule and the most recent, previously submitted revision.</p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(8)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;8&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>8</em><span class="paren">)</span></span> <em class="paragraph-heading">Current status of the postmarketing study commitment.</em>  The status of each postmarketing study should be categorized using one of the following terms that describes the study's status on the anniversary date of U.S. approval of the application or other agreed upon date:</p>
<div id="p-314.81(b)(2)(vii)(a)(8)(i)">
<p class="indent-6" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;8&lt;/em&gt;)(&lt;em&gt;i&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>i</em><span class="paren">)</span></span> <em class="paragraph-heading">Pending.</em>  The study has not been initiated, but does not meet the criterion for delayed.</p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(8)(ii)">
<p class="indent-6" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;8&lt;/em&gt;)(&lt;em&gt;ii&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>ii</em><span class="paren">)</span></span> <em class="paragraph-heading">Ongoing.</em>  The study is proceeding according to or ahead of the original schedule described under <a href="/current/title-21/section-314.81#p-314.81(b)(2)(vii)(a)(7)" class="cfr external">paragraph (b)(2)(vii)(<em>a</em>)(<em>7</em>)</a> of this section.</p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(8)(iii)">
<p class="indent-6" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;8&lt;/em&gt;)(&lt;em&gt;iii&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>iii</em><span class="paren">)</span></span> <em class="paragraph-heading">Delayed.</em>  The study is behind the original schedule described under <a href="/current/title-21/section-314.81#p-314.81(b)(2)(vii)(a)(7)" class="cfr external">paragraph (b)(2)(vii)(<em>a</em>)(<em>7</em>)</a> of this section.</p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(8)(iv)">
<p class="indent-6" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;8&lt;/em&gt;)(&lt;em&gt;iv&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>iv</em><span class="paren">)</span></span> <em class="paragraph-heading">Terminated.</em>  The study was ended before completion but a final study report has not been submitted to FDA.</p>
</div>
<div id="p-314.81(b)(2)(vii)(a)(8)(v)">
<p class="indent-6" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;8&lt;/em&gt;)(&lt;em&gt;v&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>v</em><span class="paren">)</span></span> <em class="paragraph-heading">Submitted.</em>  The study has been completed or terminated and a final study report has been submitted to FDA.</p>
</div>
</div>
<div id="p-314.81(b)(2)(vii)(a)(9)">
<p class="indent-5" data-title="314.81(b)(2)(vii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;9&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>9</em><span class="paren">)</span></span> <em class="paragraph-heading">Explanation of the study's status.</em>  Provide a brief description of the status of the study, including the patient accrual rate (expressed by providing the number of patients or subjects enrolled to date, and the total planned enrollment), and an explanation of the study's status identified under <a href="/current/title-21/section-314.81#p-314.81(b)(2)(vii)(a)(8)" class="cfr external">paragraph (b)(2)(vii)(<em>a</em>)(<em>8</em>)</a> of this section. If the study has been completed, include the date the study was completed and the date the final study report was submitted to FDA, as applicable. Provide a revised schedule, as well as the reason(s) for the revision, if the schedule under <a href="/current/title-21/section-314.81#p-314.81(b)(2)(vii)(a)(7)" class="cfr external">paragraph (b)(2)(vii)(<em>a</em>)(<em>7</em>)</a> of this section has changed since the last report.</p>
</div>
</div>
<div id="p-314.81(b)(2)(vii)(b)">
<p class="indent-4" data-title="314.81(b)(2)(vii)(&lt;em&gt;b&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>b</em><span class="paren">)</span></span> <em class="paragraph-heading">Public disclosure of information.</em>  Except for the information described in this paragraph, FDA may publicly disclose any information described in <a href="/current/title-21/section-314.81#p-314.81(b)(2)(vii)" class="cfr external">paragraph (b)(2)(vii)</a> of this section, concerning a postmarketing study, if the agency determines that the information is necessary to identify the applicant or to establish the status of the study, including the reasons, if any, for failure to conduct, complete, and report the study. Under this section, FDA will not publicly disclose trade secrets, as defined in <a href="/current/title-21/section-20.61" class="cfr external">§ 20.61 of this chapter</a>, or information, described in <a href="/current/title-21/section-20.63" class="cfr external">§ 20.63 of this chapter</a>, the disclosure of which would constitute an unwarranted invasion of personal privacy.</p>
</div>
</div>
<div id="p-314.81(b)(2)(viii)">
<p class="indent-3" data-title="314.81(b)(2)(viii)"><span class="paragraph-hierarchy"><span class="paren">(</span>viii<span class="paren">)</span></span> <em class="paragraph-heading">Status of other postmarketing studies.</em>  A status report of any postmarketing study not included under <a href="/current/title-21/section-314.81#p-314.81(b)(2)(vii)" class="cfr external">paragraph (b)(2)(vii)</a> of this section that is being performed by, or on behalf of, the applicant. A status report is to be included for any chemistry, manufacturing, and controls studies that the applicant has agreed to perform and for all product stability studies.</p>
</div>
<div id="p-314.81(b)(2)(ix)">
<p class="indent-3" data-title="314.81(b)(2)(ix)"><span class="paragraph-hierarchy"><span class="paren">(</span>ix<span class="paren">)</span></span> <em class="paragraph-heading">Log of outstanding regulatory business.</em>  To facilitate communications between FDA and the applicant, the report may, at the applicant's discretion, also contain a list of any open regulatory business with FDA concerning the drug product subject to the application (e.g., a list of the applicant's unanswered correspondence with the agency, a list of the agency's unanswered correspondence with the applicant).</p>
</div>
</div>
<div id="p-314.81(b)(3)">
<p class="indent-2" data-title="314.81(b)(3)"><span class="paragraph-hierarchy"><span class="paren">(</span>3<span class="paren">)</span></span> <em class="paragraph-heading">Other reporting</em> —</p>
<div id="p-314.81(b)(3)(i)">
<p class="indent-3" data-title="314.81(b)(3)(i)"><span class="paragraph-hierarchy"><span class="paren">(</span>i<span class="paren">)</span></span> <em class="paragraph-heading">Advertisements and promotional labeling.</em>  The applicant shall submit specimens of mailing pieces and any other labeling or advertising devised for promotion of the drug product at the time of initial dissemination of the labeling and at the time of initial publication of the advertisement for a prescription drug product. Mailing pieces and labeling that are designed to contain samples of a drug product are required to be complete, except the sample of the drug product may be omitted. Each submission is required to be accompanied by a completed transmittal Form FDA-2253 (Transmittal of Advertisements and Promotional Labeling for Drugs for Human Use) and is required to include a copy of the product's current professional labeling. Form FDA-2253 is available on the Internet at <em><a href="http://www.fda.gov/opacom/morechoices/fdaforms/cder.html" class="external" target="_blank" rel="noopener noreferrer">http://www.fda.gov/opacom/morechoices/fdaforms/cder.html</a>.</em></p>
</div>
<div id="p-314.81(b)(3)(ii)">
<p class="indent-3" data-title="314.81(b)(3)(ii)"><span class="paragraph-hierarchy"><span class="paren">(</span>ii<span class="paren">)</span></span> <em class="paragraph-heading">Special reports.</em>  Upon written request the agency may require that the applicant submit the reports under this section at different times than those stated.</p>
</div>
<div id="p-314.81(b)(3)(iii)">
<p class="indent-3" data-title="314.81(b)(3)(iii)"><span class="paragraph-hierarchy"><span class="paren">(</span>iii<span class="paren">)</span></span> <em class="paragraph-heading">Notification of a permanent discontinuance or an interruption in manufacturing.</em> </p>
<div id="p-314.81(b)(3)(iii)(a)">
<p class="indent-4" data-title="314.81(b)(3)(iii)(&lt;em&gt;a&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>a</em><span class="paren">)</span></span> An applicant of a prescription drug product must notify FDA in writing of a permanent discontinuance of manufacture of the drug product or an interruption in manufacturing of the drug product that is likely to lead to a meaningful disruption in supply of that drug in the United States if:</p>
<div id="p-314.81(b)(3)(iii)(a)(1)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>1</em><span class="paren">)</span></span> The drug product is life supporting, life sustaining, or intended for use in the prevention or treatment of a debilitating disease or condition, including any such drug used in emergency medical care or during surgery; and</p>
</div>
<div id="p-314.81(b)(3)(iii)(a)(2)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;2&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>2</em><span class="paren">)</span></span> The drug product is not a radiopharmaceutical drug product.</p>
</div>
</div>
<div id="p-314.81(b)(3)(iii)(b)">
<p class="indent-4" data-title="314.81(b)(3)(iii)(&lt;em&gt;b&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>b</em><span class="paren">)</span></span> Notifications required by <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)(a)" class="cfr external">paragraph (b)(3)(iii)(<em>a</em>)</a> of this section must be submitted to FDA electronically in a format that FDA can process, review, and archive:</p>
<div id="p-314.81(b)(3)(iii)(b)(1)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;b&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>1</em><span class="paren">)</span></span> At least 6 months prior to the date of the permanent discontinuance or interruption in manufacturing; or</p>
</div>
<div id="p-314.81(b)(3)(iii)(b)(2)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;b&lt;/em&gt;)(&lt;em&gt;2&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>2</em><span class="paren">)</span></span> If 6 months' advance notice is not possible because the permanent discontinuance or interruption in manufacturing was not reasonably anticipated 6 months in advance, as soon as practicable thereafter, but in no case later than 5 business days after the permanent discontinuance or interruption in manufacturing occurs.</p>
</div>
</div>
<div id="p-314.81(b)(3)(iii)(c)">
<p class="indent-4" data-title="314.81(b)(3)(iii)(&lt;em&gt;c&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>c</em><span class="paren">)</span></span> Notifications required by <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)(a)" class="cfr external">paragraph (b)(3)(iii)(<em>a</em>)</a> of this section must include the following information:</p>
<div id="p-314.81(b)(3)(iii)(c)(1)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;c&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>1</em><span class="paren">)</span></span> The name of the drug subject to the notification, including the NDC for such drug;</p>
</div>
<div id="p-314.81(b)(3)(iii)(c)(2)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;c&lt;/em&gt;)(&lt;em&gt;2&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>2</em><span class="paren">)</span></span> The name of the applicant;</p>
</div>
<div id="p-314.81(b)(3)(iii)(c)(3)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;c&lt;/em&gt;)(&lt;em&gt;3&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>3</em><span class="paren">)</span></span> Whether the notification relates to a permanent discontinuance of the drug or an interruption in manufacturing of the drug;</p>
</div>
<div id="p-314.81(b)(3)(iii)(c)(4)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;c&lt;/em&gt;)(&lt;em&gt;4&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>4</em><span class="paren">)</span></span> A description of the reason for the permanent discontinuance or interruption in manufacturing; and</p>
</div>
<div id="p-314.81(b)(3)(iii)(c)(5)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;c&lt;/em&gt;)(&lt;em&gt;5&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>5</em><span class="paren">)</span></span> The estimated duration of the interruption in manufacturing.</p>
</div>
</div>
<div id="p-314.81(b)(3)(iii)(d)">
<p class="indent-4" data-title="314.81(b)(3)(iii)(&lt;em&gt;d&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>d</em><span class="paren">)</span></span> </p>
<div id="p-314.81(b)(3)(iii)(d)(1)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;d&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>1</em><span class="paren">)</span></span> FDA will maintain a publicly available list of drugs that are determined by FDA to be in shortage. This drug shortages list will include the following information:</p>
<div id="p-314.81(b)(3)(iii)(d)(1)(i)">
<p class="indent-6" data-title="314.81(b)(3)(iii)(&lt;em&gt;d&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)(&lt;em&gt;i&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>i</em><span class="paren">)</span></span> The names and NDC(s) for such drugs;</p>
</div>
<div id="p-314.81(b)(3)(iii)(d)(1)(ii)">
<p class="indent-6" data-title="314.81(b)(3)(iii)(&lt;em&gt;d&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)(&lt;em&gt;ii&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>ii</em><span class="paren">)</span></span> The name of each applicant for such drugs;</p>
</div>
<div id="p-314.81(b)(3)(iii)(d)(1)(iii)">
<p class="indent-6" data-title="314.81(b)(3)(iii)(&lt;em&gt;d&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)(&lt;em&gt;iii&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>iii</em><span class="paren">)</span></span> The reason for the shortage, as determined by FDA from the following categories: Requirements related to complying with good manufacturing practices; regulatory delay; shortage of an active ingredient; shortage of an inactive ingredient component; discontinuation of the manufacture of the drug; delay in shipping of the drug; demand increase for the drug; or other reason; and</p>
</div>
<div id="p-314.81(b)(3)(iii)(d)(1)(iv)">
<p class="indent-6" data-title="314.81(b)(3)(iii)(&lt;em&gt;d&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)(&lt;em&gt;iv&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>iv</em><span class="paren">)</span></span> The estimated duration of the shortage.</p>
</div>
</div>
<div id="p-314.81(b)(3)(iii)(d)(2)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;d&lt;/em&gt;)(&lt;em&gt;2&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>2</em><span class="paren">)</span></span> FDA may choose not to make information collected to implement this paragraph available on the drug shortages list or available under section 506C(c) of the Federal Food, Drug, and Cosmetic Act (<a href="https://www.govinfo.gov/link/uscode/21/356c" class="usc external" target="_blank" rel="noopener noreferrer">21 U.S.C. 356c(c)</a>) if FDA determines that disclosure of such information would adversely affect the public health (such as by increasing the possibility of hoarding or other disruption of the availability of the drug to patients). FDA will also not provide information on the public drug shortages list or under section 506C(c) of the Federal Food, Drug, and Cosmetic Act that is protected by <a href="https://www.govinfo.gov/link/uscode/18/1905" class="usc external" target="_blank" rel="noopener noreferrer">18 U.S.C. 1905</a> or <a href="https://www.govinfo.gov/link/uscode/5/552" class="usc external" target="_blank" rel="noopener noreferrer">5 U.S.C. 552(b)(4)</a>, including trade secrets and commercial or financial information that is considered confidential or privileged under <a href="/current/title-21/section-20.61" class="cfr external">§ 20.61 of this chapter</a>.</p>
</div>
</div>
<div id="p-314.81(b)(3)(iii)(e)">
<p class="indent-4" data-title="314.81(b)(3)(iii)(&lt;em&gt;e&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>e</em><span class="paren">)</span></span> If an applicant fails to submit a notification as required under <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)(a)" class="cfr external">paragraph (b)(3)(iii)(<em>a</em>)</a> of this section and in accordance with <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)(b)" class="cfr external">paragraph (b)(3)(iii)(<em>b</em>)</a> of this section, FDA will issue a letter to the applicant informing it of such failure.</p>
<div id="p-314.81(b)(3)(iii)(e)(1)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;e&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>1</em><span class="paren">)</span></span> Not later than 30 calendar days after the issuance of such a letter, the applicant must submit to FDA a written response setting forth the basis for noncompliance and providing the required notification under <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)(a)" class="cfr external">paragraph (b)(3)(iii)(<em>a</em>)</a> of this section and including the information required under <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)(c)" class="cfr external">paragraph (b)(3)(iii)(<em>c</em>)</a> of this section; and</p>
</div>
<div id="p-314.81(b)(3)(iii)(e)(2)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;e&lt;/em&gt;)(&lt;em&gt;2&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>2</em><span class="paren">)</span></span> Not later than 45 calendar days after the issuance of a letter under <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)(e)" class="cfr external">paragraph (b)(3)(iii)(<em>e</em>)</a> of this section, FDA will make the letter and the applicant's response to the letter public, unless, after review of the applicant's response, FDA determines that the applicant had a reasonable basis for not notifying FDA as required under <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)(a)" class="cfr external">paragraph (b)(3)(iii)(<em>a</em>)</a> of this section.</p>
</div>
</div>
<div id="p-314.81(b)(3)(iii)(f)">
<p class="indent-4" data-title="314.81(b)(3)(iii)(&lt;em&gt;f&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>f</em><span class="paren">)</span></span> The following definitions of terms apply to <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iii)" class="cfr external">paragraph (b)(3)(iii)</a> of this section:</p>
<div id="p-314.81(b)(3)(iii)(f)(Drug%20shortage%20or%20shortage)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;f&lt;/em&gt;) “Drug shortage or shortage”" data-term="true"><span class="paragraph-hierarchy"><em>Drug shortage</em> or <em>shortage</em></span>   means a period of time when the demand or projected demand for the drug within the United States exceeds the supply of the drug.</p>
</div>
<div id="p-314.81(b)(3)(iii)(f)(Intended%20for%20use%20in%20the%20prevention%20or%20treatment%20of%20a%20debilitating%20disease%20or%20condition)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;f&lt;/em&gt;) “Intended for use in the prevention or treatment of a debilitating disease or condition”" data-term="true"><em class="paragraph-hierarchy">Intended for use in the prevention or treatment of a debilitating disease or condition</em>   means a drug product intended for use in the prevention or treatment of a disease or condition associated with mortality or morbidity that has a substantial impact on day-to-day functioning.</p>
</div>
<div id="p-314.81(b)(3)(iii)(f)(Life%20supporting%20or%20life%20sustaining)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;f&lt;/em&gt;) “Life supporting or life sustaining”" data-term="true"><em class="paragraph-hierarchy">Life supporting or life sustaining</em>   means a drug product that is essential to, or that yields information that is essential to, the restoration or continuation of a bodily function important to the continuation of human life.</p>
</div>
<div id="p-314.81(b)(3)(iii)(f)(Meaningful%20disruption)">
<p class="indent-5" data-title="314.81(b)(3)(iii)(&lt;em&gt;f&lt;/em&gt;) “Meaningful disruption”" data-term="true"><em class="paragraph-hierarchy">Meaningful disruption</em>   means a change in production that is reasonably likely to lead to a reduction in the supply of a drug by a manufacturer that is more than negligible and affects the ability of the manufacturer to fill orders or meet expected demand for its product, and does not include interruptions in manufacturing due to matters such as routine maintenance or insignificant changes in manufacturing so long as the manufacturer expects to resume operations in a short period of time.</p>
</div>
</div>
</div>
<div id="p-314.81(b)(3)(iv)">
<p class="indent-3" data-title="314.81(b)(3)(iv)"><span class="paragraph-hierarchy"><span class="paren">(</span>iv<span class="paren">)</span></span> <em class="paragraph-heading">Withdrawal of approved drug product from sale.</em> </p>
<div id="p-314.81(b)(3)(iv)(a)">
<p class="indent-4" data-title="314.81(b)(3)(iv)(&lt;em&gt;a&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>a</em><span class="paren">)</span></span> Within 30 calendar days of the withdrawal of an approved drug from sale, applicants who are manufacturers, repackers, or relabelers subject to <a href="/current/title-21/part-207" class="cfr external">part 207 of this chapter</a> must submit the following information about the drug, in accordance with the applicable requirements described in <a href="/current/title-21/section-207.61" class="cfr external">§§ 207.61</a> and <a href="/current/title-21/section-207.65" class="cfr external">207.65</a>:</p>
<div id="p-314.81(b)(3)(iv)(a)(1)">
<p class="indent-5" data-title="314.81(b)(3)(iv)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;1&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>1</em><span class="paren">)</span></span> The National Drug Code (NDC);</p>
</div>
<div id="p-314.81(b)(3)(iv)(a)(2)">
<p class="indent-5" data-title="314.81(b)(3)(iv)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;2&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>2</em><span class="paren">)</span></span> The identity of the drug by established name and by proprietary name, if any;</p>
</div>
<div id="p-314.81(b)(3)(iv)(a)(3)">
<p class="indent-5" data-title="314.81(b)(3)(iv)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;3&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>3</em><span class="paren">)</span></span> The new drug application number or abbreviated application number;</p>
</div>
<div id="p-314.81(b)(3)(iv)(a)(4)">
<p class="indent-5" data-title="314.81(b)(3)(iv)(&lt;em&gt;a&lt;/em&gt;)(&lt;em&gt;4&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>4</em><span class="paren">)</span></span> The date on which the drug is expected to be no longer in commercial distribution. FDA requests that the reason for withdrawal of the drug from sale be included with the information.</p>
</div>
</div>
<div id="p-314.81(b)(3)(iv)(b)">
<p class="indent-4" data-title="314.81(b)(3)(iv)(&lt;em&gt;b&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>b</em><span class="paren">)</span></span> Within 30 calendar days of the withdrawal of an approved drug from sale, applicants who are not subject to <a href="/current/title-21/part-207" class="cfr external">part 207 of this chapter</a> must submit the information listed in <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iv)(a)(1)" class="cfr external">paragraphs (b)(3)(iv)(<em>a</em>)(<em>1</em>)</a> through <a href="/current/title-21/section-314.81#p-314.81(b)(3)(iv)(a)(4)" class="cfr external">(<em>4</em>)</a> of this section. The information must be submitted either electronically or in writing to the Drug Registration and Listing Office, Food and Drug Administration, Center for Drug Evaluation and Research.</p>
</div>
<div id="p-314.81(b)(3)(iv)(c)">
<p class="indent-4" data-title="314.81(b)(3)(iv)(&lt;em&gt;c&lt;/em&gt;)"><span class="paragraph-hierarchy"><span class="paren">(</span><em>c</em><span class="paren">)</span></span> Reporting under paragraph (b)(3)(iv)<em>(<em>a</em>) of this section constitutes compliance with the requirements of <a href="/current/title-21/section-207.57" class="cfr external">§ 207.57 of this chapter</a> to update drug listing information with respect to the withdrawal from sale.</em></p>
</div>
</div>
</div>
</div>
<div id="p-314.81(c)">
<p class="indent-1" data-title="314.81(c)"><span class="paragraph-hierarchy"><span class="paren">(</span>c<span class="paren">)</span></span> <em class="paragraph-heading">General requirements</em> —</p>
<div id="p-314.81(c)(1)">
<p class="indent-2" data-title="314.81(c)(1)"><span class="paragraph-hierarchy"><span class="paren">(</span>1<span class="paren">)</span></span> <em class="paragraph-heading">Multiple applications.</em>  For all reports required by this section, the applicant shall submit the information common to more than one application only to the application first approved, and shall not report separately on each application. The submission is required to identify all the applications to which the report applies.</p>
</div>
<div id="p-314.81(c)(2)">
<p class="indent-2" data-title="314.81(c)(2)"><span class="paragraph-hierarchy"><span class="paren">(</span>2<span class="paren">)</span></span> <em class="paragraph-heading">Patient identification.</em>  Applicants should not include in reports under this section the names and addresses of individual patients; instead, the applicant should code the patient names whenever possible and retain the code in the applicant's files. The applicant shall maintain sufficient patient identification information to permit FDA, by using that information alone or along with records maintained by the investigator of a study, to identify the name and address of individual patients; this will ordinarily occur only when the agency needs to investigate the reports further or when there is reason to believe that the reports do not represent actual results obtained.</p>
</div>
</div>
<div id="p-314.81(d)"><p class="indent-1" data-title="314.81(d)"><span class="paragraph-hierarchy"><span class="paren">(</span>d<span class="paren">)</span></span> <em class="paragraph-heading">Withdrawal of approval.</em>  If an applicant fails to make reports required under this section, FDA may withdraw approval of the application and, thus, prohibit continued marketing of the drug product that is the subject of the application.</p></div>
<p class="approved">(Collection of information requirements approved by the Office of Management and Budget under control number 0910-0001)
</p>
<p class="citation">[<a href="https://www.federalregister.gov/citation/50-FR-7493" class="fr-reference" data-reference="50 FR 7493">50 FR 7493</a>, Feb. 22, 1985; <a href="https://www.federalregister.gov/citation/50-FR-14212" class="fr-reference" data-reference="50 FR 14212">50 FR 14212</a>, Apr. 11, 1985, as amended at <a href="https://www.federalregister.gov/citation/50-FR-21238" class="fr-reference" data-reference="50 FR 21238">50 FR 21238</a>, May 23, 1985; <a href="https://www.federalregister.gov/citation/55-FR-11580" class="fr-reference" data-reference="55 FR 11580">55 FR 11580</a>, Mar. 29, 1990; <a href="https://www.federalregister.gov/citation/57-FR-17983" class="fr-reference" data-reference="57 FR 17983">57 FR 17983</a>, Apr. 28, 1992; <a href="https://www.federalregister.gov/citation/63-FR-66670" class="fr-reference" data-reference="63 FR 66670">63 FR 66670</a>, Dec. 2, 1998; <a href="https://www.federalregister.gov/citation/64-FR-401" class="fr-reference" data-reference="64 FR 401">64 FR 401</a>, Jan. 5, 1999; <a href="https://www.federalregister.gov/citation/65-FR-64617" class="fr-reference" data-reference="65 FR 64617">65 FR 64617</a>, Oct. 30, 2000; <a href="https://www.federalregister.gov/citation/66-FR-10815" class="fr-reference" data-reference="66 FR 10815">66 FR 10815</a>, Feb. 20, 2001; <a href="https://www.federalregister.gov/citation/68-FR-69019" class="fr-reference" data-reference="68 FR 69019">68 FR 69019</a>, Dec. 11, 2003; <a href="https://www.federalregister.gov/citation/69-FR-18766" class="fr-reference" data-reference="69 FR 18766">69 FR 18766</a>, Apr. 8, 2004; <a href="https://www.federalregister.gov/citation/69-FR-48775" class="fr-reference" data-reference="69 FR 48775">69 FR 48775</a>, Aug. 11, 2004; <a href="https://www.federalregister.gov/citation/72-FR-58999" class="fr-reference" data-reference="72 FR 58999">72 FR 58999</a>, Oct. 18, 2007; <a href="https://www.federalregister.gov/citation/74-FR-13113" class="fr-reference" data-reference="74 FR 13113">74 FR 13113</a>, Mar. 26, 2009; <a href="https://www.federalregister.gov/citation/74-FR-37167" class="fr-reference" data-reference="74 FR 37167">74 FR 37167</a>, July 28, 2009; <a href="https://www.federalregister.gov/citation/76-FR-78539" class="fr-reference" data-reference="76 FR 78539">76 FR 78539</a>, Dec. 19, 2011; <a href="https://www.federalregister.gov/citation/80-FR-38938" class="fr-reference" data-reference="80 FR 38938">80 FR 38938</a>, July 8, 2015; <a href="https://www.federalregister.gov/citation/81-FR-60221" class="fr-reference" data-reference="81 FR 60221">81 FR 60221</a>, Aug. 31, 2016]
</p>
</div>
<script type="application/json" id="source-and-authority-data">{"origins":[{"level":"part","identifier":"314","label_level":"Part 314","hierarchy":{"title":"21","chapter":"I","subchapter":"D","part":"314"},"current":false,"authority":["\u003ca href=\"https://www.govinfo.gov/link/uscode/21/321\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e21 U.S.C. 321\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/331\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e331\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/351\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e351\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/352\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e352\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/353\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e353\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/355\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e355\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/355a\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e355a\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/355f\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e355f\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/356\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e356\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/356a\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e356a\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/356b\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e356b\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/356c\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e356c\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/356e\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e356e\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/360cc\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e360cc\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/371\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e371\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/374\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e374\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/379e\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e379e\u003c/a\u003e, \u003ca href=\"https://www.govinfo.gov/link/uscode/21/379k-1\" class=\"usc external\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e379k-1\u003c/a\u003e.\n"],"source":["\u003ca href=\"https://www.federalregister.gov/citation/50-FR-7493\" class=\"fr-reference\" data-reference=\"50 FR 7493\"\u003e50 FR 7493\u003c/a\u003e, Feb. 22, 1985, unless otherwise noted.\n"],"link":"/current/title-21/part-314","title":"Part 314"}]}</script>

</div><div class="seal-block seal-block-footer"><h6>eCFR Content</h6></div></div>      </div>
    </div>
  </div>
</div>

        </div>
      </div>
    </div>

    <div class="site-footer container-fluid" id="footer">
  <div class="container">
    <div class="col-xs-12 col-md-12">
      <div class="row">
        <div class="col-xs-3 col-md-3">
          <h2>Pages</h2>
          <ul class="list with-bullets">
            <li><a href="/">Home</a></li>
            <li><a href="/">Titles</a></li>
            <li><a href="/search">Search</a></li>
            <li><a href="/recent-changes">Recent Changes</a></li>
            <li><a href="/corrections">Corrections</a></li>
          </ul>
        </div>

        <div class="col-xs-3 col-md-3">
          <h2>Reader Aids</h2>
          <ul class="list with-bullets">
              <li>
                <a href="https://www.ecfr.gov/reader-aids/using-ecfr">Using the eCFR Point-in-Time System</a>
              </li>
              <li>
                <a href="https://www.ecfr.gov/reader-aids/understanding-the-ecfr">Understanding the eCFR</a>
              </li>
              <li>
                <a href="https://www.ecfr.gov/reader-aids/government-policy-and-ofr-procedures">Government Policy and OFR Procedures</a>
              </li>
              <li>
                <a href="https://www.ecfr.gov/reader-aids/ecfr-developer-resources">Developer Resources</a>
              </li>
          </ul>
        </div>
        <div class="col-xs-3 col-md-3">
          <h2>Information</h2>
          <ul class="list with-bullets">
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/about-this-site">About This Site</a></li>
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/about-this-site#legal-status">Legal Status</a></li>
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/privacy">Privacy</a></li>
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/accessibility">Accessibility</a></li>
            <li><a href="/reader-aids/government-policy-and-ofr-procedures/foia">FOIA</a></li>
            <li><a href="https://www.archives.gov/eeo/policy/no-fear-notice.html">No Fear Act</a></li>
            <li><a href="https://www.archives.gov/federal-register/contact.html#coop">Continuity Information</a></li>
          </ul>
        </div>

        <div class="col-xs-3 col-md-3">
          <h2>My eCFR</h2>
          <ul class="list with-bullets">
            <li>
              <a href="/my/subscriptions">My Subscriptions</a>
            </li>
            <li>
              <a data-turbo="false" href="https://www.ecfr.gov/auth/sign_in?jwt=eyJhbGciOiJIUzI1NiJ9.eyJub3RpZmljYXRpb25zIjp7ImluZm8iOiJZb3Ugd2lsbCBiZSByZWRpcmVjdGVkIGJhY2sgdG8gdGhlIGVDRlIgYWZ0ZXIgeW91IGhhdmUgc2lnbmVkIGluIG9yIGNyZWF0ZWQgYW4gYWNjb3VudC4ifX0.-sYkHWfC02yb0CpuUqmPkxxnF0yzlNHaS5520hYIUy8&amp;redirect_to=https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-314/subpart-B/section-314.81">Sign In / Sign Up</a>
            </li>
          </ul>
        </div>


      </div>
    </div>
  </div>
</div>

</body></html>
